Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

First MERS Virus Treatment Found Safe

An experimental treatment for Middle East respiratory syndrome, or MERS, infections made from antibodies produced in cattle is shown in a clinical trial to be safe for patients. . . . → Read More: First MERS Virus Treatment Found Safe

Stem Cell Patches Shown to Treat Heart Attack Damage

Human heart muscle patches made from stem cells helped fix damage and improve heart functions in tests with pigs induced with heart attacks. . . . → Read More: Stem Cell Patches Shown to Treat Heart Attack Damage

Neuro Informatics Software Released to Open Source

A collection of software from the Blue Brain Project for reconstructing models of mammal brain circuitry is being made freely available to the research community. . . . → Read More: Neuro Informatics Software Released to Open Source

HIV Drugs Formulated Into Once-Weekly Capsules

Medical and engineering researchers developed and tested in pigs a technique for packing several drugs into a capsule taken once a week to prevent and treat HIV infections. . . . → Read More: HIV Drugs Formulated Into Once-Weekly Capsules

Genomic Analysis Company Adds Body Composition Profiles

A company analyzing genomics and microbiome factors to extend human life spans is adding an evaluation of body composition to its tool kit. . . . → Read More: Genomic Analysis Company Adds Body Composition Profiles

Ingestible Sensors Measure Gases in Stomach, Gut

Researchers in Australia created a sensing device packed in a standard-size drug capsule that measures gas concentrations in the digestive tract in real time. . . . → Read More: Ingestible Sensors Measure Gases in Stomach, Gut

Lilly, Tech Company Study Diabetes Experiences

A maker of diabetes drugs and digital health enterprise are beginning a study of real world experiences with self-management and education among people with diabetes. . . . → Read More: Lilly, Tech Company Study Diabetes Experiences

Celgene Acquires Cancer Drug Start-Up in $7B Deal

The biopharmaceutical company Celgene Corp. is acquiring Impact Biomedicines Inc., a developer of drugs to treat a type of blood-related cancer, in a deal valued as much as $7 billion. . . . → Read More: Celgene Acquires Cancer Drug Start-Up in $7B Deal

Highly Targeted Opioid Designed to Avoid Side Effects

A pharmacology team decoded complex opioid proteins in the brain to design a compound that can relieve pain, but avoid the dangerous adverse effects causing addiction and overdoses. . . . → Read More: Highly Targeted Opioid Designed to Avoid Side Effects

Biotech, Microsoft Partner on Immune System Diagnostics

A company that analyzes immune system genomics is collaborating with Microsoft Corporation to develop early-stage disease diagnostics. . . . → Read More: Biotech, Microsoft Partner on Immune System Diagnostics